Measuring adherence to antiretroviral treatment in resource-poor settings: The feasibility of collecting routine data for key indicators

被引:33
作者
Chalker, John C. [1 ]
Andualem, Tenaw [2 ]
Gitau, Lillian N. [3 ]
Ntaganira, Joseph
Obua, Celestino [4 ]
Tadeg, Hailu [2 ]
Waako, Paul [4 ]
Ross-Degnan, Dennis [5 ,6 ]
机构
[1] Management Sci Hlth, Ctr Pharmaceut Management, Arlington, VA USA
[2] Management Sci Hlth, Addis Ababa, Ethiopia
[3] INRUD, Management Sci Hlth, Nairobi, Kenya
[4] Makerere Univ, Sch Med, Dept Pharmacol & Therapeut, Kampala, Uganda
[5] Harvard Univ, Sch Med, Boston, MA USA
[6] Harvard Pilgrim Hlth Care, Boston, MA USA
[7] Initiat Adherence Antiretrovirals, Int Network Rational Use Drugs, Arlington, VA 22203 USA
关键词
HIV PROTEASE INHIBITORS; SELF-REPORT; VIRAL SUPPRESSION; PHARMACY REFILL; THERAPY; MALAWI; MEDICATION; RESISTANCE; INFECTION; VALIDITY;
D O I
10.1186/1472-6963-10-43
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: An East African survey showed that among the few health facilities that measured adherence to antiretroviral therapy, practices and definitions varied widely. We evaluated the feasibility of collecting routine data to standardize adherence measurement using a draft set of indicators. Methods: Targeting 20 facilities each in Ethiopia, Kenya, Rwanda, and Uganda, in each facility we interviewed up to 30 patients, examined 100 patient records, and interviewed staff. Results: In 78 facilities, we interviewed a total of 1,631 patients and reviewed 8,282 records. Difficulties in retrieving records prevented data collection in two facilities. Overall, 94.2% of patients reported perfect adherence; dispensed medicine covered 91.1% of days in a six month retrospective period; 13.7% of patients had a gap of more than 30 days in their dispensed medication; 75.8% of patients attended clinic on or before the date of their next appointment; and 87.1% of patients attended within 3 days. In each of the four countries, the facility-specific median indicators ranged from: 97%-100% for perfect self-reported adherence, 90%-95% of days covered by dispensed medicines, 2%-19% of patients with treatment gaps of 30 days or more, and 72%-91% of appointments attended on time. Individual facilities varied considerably. The percentages of days covered by dispensed medicine, patients with more than 95% of days covered, and patients with a gap of 30 days or more were all significantly correlated with the percentages of patients who attended their appointments on time, within 3 days, or within 30 days of their appointment. Self reported recent adherence in exit interviews was significantly correlated only with the percentage of patients who attended within 3 days of their appointment. Conclusions: Field tests showed that data to measure adherence can be collected systematically from health facilities in resource-poor settings. The clinical validity of these indicators is assessed in a companion article. Most patients and facilities showed high levels of adherence; however, poor levels of performance in some facilities provide a target for quality improvement efforts.
引用
收藏
页数:11
相关论文
共 31 条
[1]   Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature [J].
Ammassari, A ;
Trotta, MP ;
Murri, R ;
Castelli, F ;
Narciso, P ;
Noto, P ;
Vecchiet, J ;
D'Arminio Monforte, A ;
Wu, AW ;
Antinori, A .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 :S123-S127
[2]   Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring [J].
Arnsten, JH ;
Demas, PA ;
Farzadegan, H ;
Grant, RW ;
Gourevitch, MN ;
Chang, CJ ;
Buono, D ;
Eckholdt, H ;
Howard, AA ;
Schoenbaum, EE .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) :1417-1423
[3]   Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression [J].
Bangsberg, David R. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) :939-941
[4]   Adherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi [J].
Bell, David J. ;
Kapitao, Yamika ;
Sikwese, Rosemary ;
van Oosterhout, Joep J. ;
Lalloo, David G. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (05) :560-563
[5]   Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy [J].
Bisson, Gregory P. ;
Gross, Robert ;
Bellamy, Scarlett ;
Chittams, Jesse ;
Hislop, Michael ;
Regensberg, Leon ;
Frank, Ian ;
Maartens, Gary ;
Nachega, Jean B. .
PLOS MEDICINE, 2008, 5 (05) :777-789
[6]  
Chalker John, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P193, DOI 10.1177/1545109708320687
[7]   Variations in patients' adherence to medical recommendations - A quantitative review of 50 years of research [J].
DiMatteo, MR .
MEDICAL CARE, 2004, 42 (03) :200-209
[8]   Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting [J].
Fairley, CK ;
Permana, A ;
Read, TRH .
HIV MEDICINE, 2005, 6 (05) :366-369
[9]   Assessment of adherence to antiviral therapy in HIV-infected children using the medication event monitoring system, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping [J].
Farley, J ;
Hines, S ;
Musk, A ;
Ferrus, S ;
Tepper, V .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (02) :211-218
[10]  
FARLEY J, 2007, 791 2007 HIV AIDS IM